Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins

Anesthesiology

Volumn 92, Issue 5, 2000, Pages 1400-1407

  Toller, Wolfgang G ^a   Kersten, Judy R ^a   Gross, Eric R ^a   Pagel, Paul S ^a   Warltier, David C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Myocardial ischemia; Pertussis toxin

Indexed keywords

ADENOSINE TRIPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOFLURANE; MICROSPHERE; NICORANDIL; PERTUSSIS TOXIN; POTASSIUM CHANNEL; PROTEIN KINASE C INHIBITOR; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOG; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HEART VENTRICLE PRESSURE; HYPOTHESIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034101316     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200005000-00031     Document Type: Article

References (35)

1. Kersten, JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997; 86:1128-39
2. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten TR: Isoflurane-enhanced recovery of canine stunned myocardium: A role for protein kinase C? ANESTHESIOLOGY 1999; 91:713-22
3. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 86:699-709
4. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
5. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA: Mechanisms of isoflurane-inducecl myocardial preconditioning in rabbits. ANESTHESIOLOGY 1999; 90:812-21
6. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. ANESTHESIOLOGY 1999; 91:1437-46
7. ATP) channels mediate the cardioprotective effects of desflurane (abstract). ANESTHESIOLOGY 1999; 91:A625
8. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 1990; 259:H820-6
9. Schultz JE, Hsu AK, Barbieri JT, Li PL, Gross GJ: Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol 1998; 275:H495-500
10. + current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes. J Pharmacol Exp Ther 1989; 250:278-85
11. American Physiologic Society: Guiding Principles in the Care and Use of Animals. Bethesda, American Physiologic Society, 1991
12. Committee to Revise the Guide for the Care and Use of Laboratory Animals: Clark JD, Baldwin RL, Bayne KA, Brown MJ, Gebhart GF, Gonder JC, Gwathmey JK, Keeling ME, Kohn DF, Robb JW, Smith OA, Steggerda JD, Vandenbergh JG, White WJ, Williams-Blangero S, Vande-Berg JL: Guide for the Care and Use of Laboratory Animals. Edited by Grossblatt N. National Academy Press, Washington, DC, 1996
13. ATP) channels. ANESTHESIOLOGY 1996; 85:794-807
14. Steffey EP, Howland D Jr: Isoflurane potency in the dog and cat. Am J Vet Res 1977; 38:1833-6
15. Mizumura T, Nithipatikom K, Gross GJ: Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995; 29:482-9
16. Miura K, Kano S, Nakai T, Satoh K, Hoshi K, Ichihara K: Inhibitory effects of glibenclamide and pertussis toxin on the attenuation of ischemia-induced myocardial acidosis following ischemic preconditioning in dogs. Jpn Circ J 1997; 61:709-14
17. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993; 264: H1327-36
18. + channels in excised membrane patches is mediated by PKC. Am J Physiol 1999; 276:H488-95
19. Downey JM, Cohen MV: Signal transduction in ischemic preconditioning. Z Kardiol 1995; 84:77-86
20. + channels: A possible mechanistic link to ischemic preconditioning. Circ Res 1996; 79:399-406
21. Thornton JD, Liu GS, Downet JM: Pretreatment with pertussis toxin blocks the protective effects of preconditioning: Evidence for a G-protein mechanism. J Mol Cell Cardiol 1993; 25:311-20
22. Hu K, Nattel S: Mechanisms of ischemic preconditioning in rat hearts. Involvement of α1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995; 92:2259-65
23. Ytrehus K, Liu Y, Downey JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266:H1145-52
24. + channels in rabbit ventricular myocytes. Biochem Biophys Res Commun 1996; 229:852-6
25. 1 receptor activation. AmJ Physiol 1997; 272:H325-33
26. Kersten JR, Gross GJ, Pagel PS, Warltier DC: Activation of adenosine triphosphate-regulated potassium channels: Mediation of cellular and organ protection. ANESTHESIOLOGY 1998; 88:495-513
27. ATP channels activated by adenosine (abstract). ANESTHESIOLOGY 1999; 91: A328
28. Endoh M, Maruyama M, Iijima T: Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am J Physiol 1985; 249:H309-20
29. Piacentini L, Wainwright CL, Parratt JR: The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res 1993; 27:674-80
30. Fleming JW, Hodges TD, Watanabe AM: Pertussis toxin-treated dog: A whole animal model of impaired inhibitory regulation of adenylate cyclase. Circ Res 1988; 62:992-1000
31. ATP channels. Am J Physiol 1998; 274:H909-14
32. Liu Y, Downey JM: Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein. Cardiovasc Res 1993; 27:608-11
33. ATP channel but not by its nitrate-like properties in dogs. Cardiovasc Res 1996; 32:274-85
34. Sato T, Sasaki N, O'Rourke B, Marban E: Nicorandil activates mitochondrial ATP-dependent potassium channels in rabbit ventricular cells (abstract). Circulation 1998; 98(Suppl):A1799
35. Liu Y, Sato T, O'Rourke B, Marban E: Mitochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998; 97:2463-9